86.90.E - Other human health activities notelsewhere classified
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
32.50.Z - Manufacture of medical and dental instruments and supplies
71.20.B - Other technical testing and analysis
72.19.Z - Other research and experimental development on natural sciences and engineering
73.11.Z - Advertising agencies activities
73.20.Z - Market research and public opinion polling
86.21.Z - General medical practice activities
86.22.Z - Specialist medical practice activities
2019 | 2020 | ||
---|---|---|---|
M PLN | M PLN | % | |
Gross profit (loss) | -0 | -0,3 | -1567,7 |
EBITDA | -0 | -0 | -9 |
Short time liabilities | 0 | 0,9 | 3731,5 |
Equity capital | -0 | -0,3 | -1861,6 |
Operating profit (EBIT) | -0 | -0,1 | -181,5 |
Assets | 0 | 6,4 | 75 788 |
Net profit (loss) | -0 | -0,3 | -1567,7 |
Cash | 0 | 1,9 | 45 382,9 |
Liabilities and provisions for liabilities | 0 | 6,7 | 27 519,9 |
Net income from sale | 0,1 | 1 | 1639,4 |
Working assets | 0 | 3,7 | 43 814 |
Depreciation | 0 | 0 | -∞ |
% | % | p.p. | |
Profitability of capital | 112,1 | 95,3 | -16,8 |
Equity capital to total assets | -188,1 | -4,9 | 183,2 |
Gross profit margin | -30,5 | -29,2 | 1,3 |
EBITDA Margin | -30,5 | -1,9 | 28,6 |
Days | Days | Days | |
Short term commitment turnover cycle | 152 | 335 | 183 |
Current financial liquidity indicator | 0.3470780551433563 | 3.9411795139312744 | 3,6 |
Net dept to EBITDA | 0.23037266731262207 | -233.88711547851562 | -234,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane